Get started
Author

Ahuva Odenheimer-Bergman

Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
2019 · Bradon R. McDonald, Tania Contente-Cuomo, et al. · Science Translational Medicine · 306
PDF
Analysis of recurrently protected genomic regions in cell-free DNA found in urine
2021 · Havell Markus, Jun Zhao, et al. · Science Translational Medicine · 97
PDF
Gifsy-1 Prophage IsrK with Dual Function as Small and Messenger RNA Modulates Vital Bacterial Machineries
2016 · Tal Hershko-Shalev, Ahuva Odenheimer-Bergman, et al. · PLoS Genetics · 41
PDF
Plasma metagenomic sequencing to detect and quantify bacterial DNA in ICU patients suspected of sepsis: A proof-of-principle study
2021 · Mehreen T. Kisat, Ahuva Odenheimer-Bergman, et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 6
Biology of Circulating DNA in Health and Disease
2022 · Ahuva Odenheimer-Bergman, Havell Markus, et al. · WORLD SCIENTIFIC eBooks · 3
Abstract P4-01-21: Multiplexed targeted digital sequencing of circulating tumor DNA to detect minimal residual disease in early and locally advanced breast cancer
2019 · BR McDonald, T Contente-Cuomo, et al. · Cancer Research · 2
Correction: Gifsy-1 Prophage IsrK with Dual Function as Small and Messenger RNA Modulates Vital Bacterial Machineries
2017 · Tal Hershko-Shalev, Ahuva Odenheimer-Bergman, et al. · PLoS Genetics · 1
PDF
Detection of FGFR fusions in intrahepatic cholangiocarcinoma using targeted RNA sequencing.
2021 · Maria Farooq, Havell Markus, et al. · Journal of Clinical Oncology
Abstract A51: Personalized monitoring of treatment response using Targeted Digital Sequencing of circulating tumor DNA
2020 · Bradon R. McDonald, Tania Contente-Cuomo, et al. · Clinical Cancer Research
Abstract PR14: Sub-nucleosomal fragmentation in urine cell-free DNA
2020 · Havell Markus, Jun Zhao, et al. · Clinical Cancer Research
Works count: 10
Citation count: 456
H-index: 4
I10-index: 3
Year
Topic
Type